<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="slug">identification-of-protein-kinase-c-beta-2-regulate</item><item key="factor_count">4</item><item key="sample_count">12</item><item key="tags"><item>acute myeloid leukemia</item><item>cell</item><item>dendritic</item><item>leukemia</item><item>line</item><item>myeloid leukemia</item><item>protein</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-54484</item><item key="id">2131</item><item key="name">Identification of protein kinase C beta 2 regulated genes early in dendritic cell differentiation</item></item><item><item key="slug">identification-of-targets-specifically-regulated-b</item><item key="factor_count">1</item><item key="sample_count">4</item><item key="tags"><item>cancer</item><item>cell</item><item>central</item><item>line</item><item>osteosarcoma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-35512</item><item key="id">4404</item><item key="name">Identification of targets specifically regulated by a 'super hybrid p53'</item></item><item><item key="slug">identification-of-the-receptor-tyrosine-kinase-axl</item><item key="factor_count">0</item><item key="sample_count">9</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>disease</item><item>estrogen</item><item>genome</item><item>hormone</item><item>line</item><item>median</item><item>nucleotide</item><item>protein</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-21832</item><item key="id">3659</item><item key="name">Identification of the receptor tyrosine kinase AXL in triple negative breast cancer as a novel target for the human miR-34a microRNA (gene expression)</item></item><item><item key="slug">identification-of-wisp1-as-an-important-survival-f</item><item key="factor_count">1</item><item key="sample_count">6</item><item key="tags"><item>cell</item><item>musculoskeletal system</item><item>protein</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-37603</item><item key="id">2051</item><item key="name">Identification of WISP1 as an important survival factor in human mesenchymal stem cells</item></item><item><item key="slug">identify-the-cancer-stem-cells-expression-characte</item><item key="factor_count">1</item><item key="sample_count">6</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>ovarian cancer</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-43657</item><item key="id">4619</item><item key="name">Identify the cancer stem cells expression characteristics in ovarian and breast cancer</item></item><item><item key="slug">il-17-induces-an-expanded-range-of-downstream-gene</item><item key="factor_count">2</item><item key="sample_count">12</item><item key="tags"><item>cell</item><item>cytokine</item><item>disease</item><item>epidermis</item><item>kcs</item><item>psoriasis</item><item>skin</item><item>skin disease</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-52361</item><item key="id">2116</item><item key="name">IL-17 induces an expanded range of downstream genes in reconstituted human epidermis model</item></item><item><item key="slug">il-4-mediated-gene-expression-profiles-in-vascular</item><item key="factor_count">3</item><item key="sample_count">13</item><item key="tags"><item>atherosclerosis</item><item>cell</item><item>cell adhesion molecule</item><item>chromatin</item><item>deep</item><item>disease</item><item>endothelial cell</item><item>endothelium</item><item>genome</item><item>interleukin</item><item>monocyte</item><item>vascular disease</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-28117</item><item key="id">4006</item><item key="name">IL-4 mediated gene expression profiles in vascular endothelial cells</item></item><item><item key="slug">imatinib-therapy-of-chronic-myeloid-leukemia-resto</item><item key="factor_count">2</item><item key="sample_count">27</item><item key="tags"><item>bone</item><item>bone marrow</item><item>cell</item><item>chronic myeloid leukemia</item><item>class</item><item>genome</item><item>hematopoietic system</item><item>leukemia</item><item>myeloid leukemia</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-33075</item><item key="id">2166</item><item key="name">Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell cycle progression</item></item><item><item key="slug">immune-profile-and-mitotic-index-of-metastatic-mel</item><item key="factor_count">0</item><item key="sample_count">44</item><item key="tags"><item>cd3d</item><item>cell</item><item>melanoma</item><item>metastatic melanoma</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-19234</item><item key="id">3503</item><item key="name">Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival.</item></item><item><item key="slug">impact-of-gene-expression-profiling-based-risk-str</item><item key="factor_count">0</item><item key="sample_count">46</item><item key="tags"><item>bone</item><item>bone marrow</item><item>cell</item><item>multiple myeloma</item><item>myeloma</item><item>plasma cell</item></item><item key="species">human</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-31504</item><item key="id">4208</item><item key="name">Impact of Gene Expression Profiling Based Risk Stratification in Patients with Myeloma Receiving Initial Therapy with Lenalidomide and Dexamethasone</item></item></data></biogps>
